The Oncosearch | Oncotarget

CBP501 induces immunogenic tumor cell death and CD8 T cell infiltration into tumors in combination with platinum, and increases the efficacy of immune checkpoint inhibitors against tumors in mice Priority Research Paper

Keiichi Sakakibara, Takuji Sato, Donald W. Kufe, Daniel D. VonHoff, Takumi Kawabe

Published Sep 16, 2017 · Vol. 8, No. 45 · pp. 78277-78288

Immunization with recombinant rabies virus expressing Interleukin-18 exhibits enhanced immunogenicity and protection in mice Research Paper

Weiwei Gai, Wenwen Zheng, Chong Wang, Gary Wong, Yanyan Song, Xuexing Zheng

Published Sep 16, 2017 · Vol. 8, No. 53 · pp. 91505-91515

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions Research Paper

Carl-Olof Hillerdal, Rita Ã–tvÃ¶s, TÃ¼nde SzatmÃ¡ri, Sulaf Abd Own, Gunnar Hillerdal, Ã…sa-Lena Dackland, Katalin Dobra, Anders Hjerpe

Published Sep 15, 2017 · Vol. 8, No. 47 · pp. 82885-82896

Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials Research Paper

Judit Fazekas-Singer, Neydher BerroterÃ¡n-Infante, Christina Rami-Mark, Monika Dumanic, Miroslawa Matz, Michael Willmann, Fritz Andreae, Josef Singer, Wolfgang Wadsak, Markus Mitterhauser, Erika Jensen-Jarolim

Published Sep 15, 2017 · Vol. 8, No. 47 · pp. 83128-83141

Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy Research Paper

Jonathan Cole, Marie-Christine Guiot, Michel Gravel, Cynthia Bernier, Gordon C. Shore, Anne Roulston

Published Sep 12, 2017 · Vol. 8, No. 44 · pp. 77846-77859

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination Research Paper

Erika Nakatsuka, Kenjiro Sawada, Koji Nakamura, Akihito Yoshimura, Yasuto Kinose, Michiko Kodama, Kae Hashimoto, Seiji Mabuchi, Hiroshi Makino, Eiichi Morii, Yoichi Yamaguchi, Takeshi Yanase, Akiko Itai, Ken-ichirou Morishige, Tadashi Kimura

Published Sep 12, 2017 · Vol. 8, No. 52 · pp. 89887-89902

Prediction of thyroidal ¹³¹I effective half-life in patients with Gravesâ€™ disease Research Paper

Ruiguo Zhang, Guizhi Zhang, Renfei Wang, Jian Tan, Yajing He, Zhaowei Meng

Published Sep 12, 2017 · Vol. 8, No. 46 · pp. 80934-80940

EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma Research Paper

Emily Capone, Francesco Giansanti, Sara Ponziani, Alessia Lamolinara, Manuela Iezzi, Annamaria Cimini, Francesco Angelucci, Rossana La Sorda, Vincenzo De Laurenzi, Pier Giorgio Natali, Rodolfo Ippoliti, Stefano Iacobelli, Gianluca Sala

Published Sep 8, 2017 · Vol. 8, No. 56 · pp. 95412-95424

Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824) Research Paper

Caroline Jochems, Sarah R. Tritsch, Ping Wang, Zhen Su, Patrick Soon-Shiong, Hing C. Wong, James L. Gulley, Jeffrey Schlom

Published Sep 8, 2017 · Vol. 8, No. 43 · pp. 75217-75231

Soluble chemokine (C-X-C motif) ligand 16 (CXCL16) in urine as a novel biomarker candidate to identify high grade and muscle invasive urothelial carcinomas Research Paper

Kerstin Lang, Nadine Bonberg, Sibylle Robens, Thomas Behrens, Jan Hovanec, Thomas Deix, Katharina Braun, Florian Roghmann, Joachim Noldus, Volker Harth, Karl-Heinz JÃ¶ckel, Raimund Erbel, Yu Chun Tam, Andrea Tannapfel, Heiko Udo KÃ¤fferlein, Thomas BrÃ¼ning

Published Sep 8, 2017 · Vol. 8, No. 62 · pp. 104946-104959

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries Research Paper

Katja Klausz, Michael Cieker, Christian Kellner, Hans-Heinrich Oberg, Dieter Kabelitz, Thomas Valerius, Renate Burger, Martin Gramatzki, Matthias Peipp

Published Sep 5, 2017 · Vol. 8, No. 44 · pp. 77552-77566

Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies Priority Research Paper

Robert J. Cardnell, Lerong Li, Triparna Sen, Rasha Bara, Pan Tong, Junya Fujimoto, Abbie S. Ireland, Matthew R. Guthrie, Sheila Bheddah, Upasana Banerjee, Nene N. Kalu, You-Hong Fan, Scott J. Dylla, Faye M. Johnson, Ignacio I. Wistuba, Trudy G. Oliver, John V. Heymach, Bonnie S. Glisson, Jing Wang, Lauren A. Byers

Published Sep 1, 2017 · Vol. 8, No. 43 · pp. 73419-73432

Breast cancer induced nociceptor aberrant growth and collateral sensory axonal branching Research Paper

Matt Austin, Laura Elliott, Niovi Nicolaou, Anna Grabowska, Richard P. Hulse

Published Sep 1, 2017 · Vol. 8, No. 44 · pp. 76606-76621

Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer Research Paper

Xin-Jun Cai, Zeng Wang, Jia-Wei Cao, Jian-Jun Ni, Ying-Ying Xu, Jun Yao, Hong Xu, Fang Liu, Gao-Yi Yang

Published Aug 24, 2017 · Vol. 8, No. 48 · pp. 84248-84257

MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G_D2 immunotherapy Research Paper

Brian H. Kushner, Michael P. LaQuaglia, Shakeel Modak, Suzanne L. Wolden, Ellen M. Basu, Stephen S. Roberts, Kim Kramer, Karima Yataghene, Irene Y. Cheung, Nai-Kong V. Cheung

Published Aug 24, 2017 · Vol. 8, No. 56 · pp. 95293-95302

Size-based detection of sarcoma circulating tumor cells and cell clusters Research Paper

Masanori Hayashi, Peixuan Zhu, Gregory McCarty, Christian F. Meyer, Christine A. Pratilas, Adam Levin, Carol D. Morris, Catherine M. Albert, Kyle W. Jackson, Cha-Mei Tang, David M. Loeb

Published Aug 24, 2017 · Vol. 8, No. 45 · pp. 78965-78977

Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells Research Paper

Vijay Pandey, Min Zhang, Qing-Yun Chong, Mingliang You, Ainiah Rushdiana Raquib, Amit K. Pandey, Dong-Xu Liu, Liang Liu, Lan Ma, Sudhakar Jha, Zheng-Sheng Wu, Tao Zhu, Peter E. Lobie

Published Aug 24, 2017 · Vol. 8, No. 44 · pp. 77268-77291

A novel polyamine blockade therapy activates an anti-tumor immune response Research Paper

Eric T. Alexander, Allyson Minton, Molly C. Peters, Otto Phanstiel IV, Susan K. Gilmour

Published Aug 24, 2017 · Vol. 8, No. 48 · pp. 84140-84152

Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma Research Paper

Ching-Ping Tseng, Kong-Kit Leong, Miaw-Jene Liou, Hsueh-Ling Hsu, Hung-Chih Lin, Yi-An Chen, Jen-Der Lin

Published Aug 24, 2017 · Vol. 8, No. 44 · pp. 77453-77464

High mobility group protein B1 is a predictor of poor survival in ovarian cancer Research Paper

Lee R. Machado, Paul M. Moseley, Robert Moss, Suha Deen, Christopher Nolan, Ian Spendlove, Judith M. Ramage, Stephen YT. Chan, Lindy G. Durrant

Published Aug 24, 2017 · Vol. 8, No. 60 · pp. 101215-101223

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

CBP501 induces immunogenic tumor cell death and CD8 T cell infiltration into tumors in combination with platinum, and increases the efficacy of immune checkpoint inhibitors against tumors in mice Priority Research Paper

Immunization with recombinant rabies virus expressing Interleukin-18 exhibits enhanced immunogenicity and protection in mice Research Paper

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions Research Paper

Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials Research Paper

Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy Research Paper

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination Research Paper

Prediction of thyroidal ¹³¹I effective half-life in patients with Gravesâ€™ disease Research Paper

EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma Research Paper

Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824) Research Paper

Soluble chemokine (C-X-C motif) ligand 16 (CXCL16) in urine as a novel biomarker candidate to identify high grade and muscle invasive urothelial carcinomas Research Paper

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries Research Paper

Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies Priority Research Paper

Breast cancer induced nociceptor aberrant growth and collateral sensory axonal branching Research Paper

Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer Research Paper

MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G_D2 immunotherapy Research Paper

Size-based detection of sarcoma circulating tumor cells and cell clusters Research Paper

Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells Research Paper

A novel polyamine blockade therapy activates an anti-tumor immune response Research Paper

Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma Research Paper

High mobility group protein B1 is a predictor of poor survival in ovarian cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

CBP501 induces immunogenic tumor cell death and CD8 T cell infiltration into tumors in combination with platinum, and increases the efficacy of immune checkpoint inhibitors against tumors in mice Priority Research Paper

Immunization with recombinant rabies virus expressing Interleukin-18 exhibits enhanced immunogenicity and protection in mice Research Paper

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions Research Paper

Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials Research Paper

Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy Research Paper

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination Research Paper

Prediction of thyroidal 131I effective half-life in patients with Gravesâ€™ disease Research Paper

EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma Research Paper

Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824) Research Paper

Soluble chemokine (C-X-C motif) ligand 16 (CXCL16) in urine as a novel biomarker candidate to identify high grade and muscle invasive urothelial carcinomas Research Paper

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries Research Paper

Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies Priority Research Paper

Breast cancer induced nociceptor aberrant growth and collateral sensory axonal branching Research Paper

Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer Research Paper

MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-GD2 immunotherapy Research Paper

Size-based detection of sarcoma circulating tumor cells and cell clusters Research Paper

Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells Research Paper

A novel polyamine blockade therapy activates an anti-tumor immune response Research Paper

Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma Research Paper

High mobility group protein B1 is a predictor of poor survival in ovarian cancer Research Paper

Prediction of thyroidal ¹³¹I effective half-life in patients with Gravesâ€™ disease Research Paper

MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G_D2 immunotherapy Research Paper